
Cecilia Ong, MD
General Surgery, Surgical Oncology
Accepts New Patients
Request Appointment
Locations for Cecilia Ong, MD
-
Map pinA
Hinsdale
-
UChicago Medicine AdventHealth Surgical Oncology Hinsdale
-
Map pinB
Chicago
-
University of Chicago - Surgical Oncology
UChicago Faculty Physicians hold faculty positions with the University of Chicago and provide care for patients on the academic health system's main campus in Hyde Park and in care centers throughout the Chicago region. UChicago Faculty Physicians who provide services at UChicago Medicine AdventHealth Bolingbrook, Hinsdale, La Grange and GlenOaks hospitals are independent providers with privileges at those hospitals. Except as otherwise denoted, independent providers are not employees or agents of UChicago Medicine AdventHealth Bolingbrook, Hinsdale, La Grange and GlenOaks hospitals.
Expertise of Cecilia Ong, MD
- Biography
-
Cecilia Ong, MD, is a board-certified surgeon. Her specialties include:
- Surgical Oncology
- General Surgery
- Gastrointestinal Cancers
- Liver Cancer
- Bile Duct Cancer
- Pancreatic Cancer
- Stomach Cancer
- Appendix Cancer
- Neuroendocrine Tumors
- Peritoneal Cancer
- Sarcomas
- Care Philosophy
-
Dr. Ong’s patient-centered approach and compassionate care ensures that she understands her patients' individual diagnosis, concerns and preferences working together they can develop a customized treatment plan. She believes in open communication so her patients are well informed about their procedure option(s) and expected outcomes. Dr. Ong is fellowship trained in complex cancer surgeries.
- Areas Served
- Hinsdale, IL | Chicago, IL
- Languages Spoken
- English, Vietnamese
- Education
-
Duke University School of Medicine
- Residencies
-
General Surgery at Duke University Medical Center
- Fellowships
-
Surgical Oncology at University of Chicago Medical Center
- Medical Organization Memberships and Committees
-
Americas Hepato-Pancreato-Biliary Association
American College of Surgeons
Society of Surgical Oncology
- Board Certification
-
Surgery: The American Board of Surgery
- Publications
-
Bansal VV, Mitchell O, Bregio C, Witmer HDD, Dhiman A, Godley FA, Ong C, Berger Y, Reddy B, Churpek JE, Drazer MW, Eng OS, Kindler HL, Turaga KK. ASO Visual Abstract Venous Thromboembolism in Peritoneal Mesothelioma-Uncovering the Hidden Risk. Ann Surg Oncol. 2024 Mar 08. PMID 38457102.
Vierra M, Bansal VV, Morgan RB, Witmer HDD, Reddy B, Dhiman A, Godley FA, Ong CT, Belmont E, Polite B, Shergill A, Turaga KK, Eng OS. ASO Visual Abstract Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2024 01; 31(1) Call657-658-PMID 37814180.
Vierra M, Bansal VV, Morgan RB, Witmer HDD, Reddy B, Dhiman A, Godley FA, Ong CT, Belmont E, Polite B, Shergill A, Turaga KK, Eng OS. Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2024 Jan; 31(1) Call645-654-PMID 37737968.
Bansal VV, Witmer HDD, Lam A, Morgan RB, Godley F, Ong CT, Dhiman A, Eng OS, Turaga KK. Design and Implementation of a Learner-Centered Self-Paced Peritoneal Oncology Education Program. Ann Surg Oncol. 2023 Nov; 30(12)6983-6986. PMID 37632574.
Dhiman A, Kothary V, Witmer HDD, Bregio C, Sood D, Ong CT, Polite B, Eng OS, Shergill A, Turaga KK. Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery. Ann Surg. 2023 12 01; 278(6) Call925-931-PMID 36994703.
Morgan RB, Dhiman A, Sood D, Ong CT, Wu X, Shergill A, Polite B, Turaga KK, Eng OS. Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J Surg Oncol. 2023 Apr; 127(5) Call831-840-PMID 36636792.
Ong CT, Dhiman A, Smith A, Jose A, Kallakuri P, Belanski J, Sood D, Witmer HDD, Morgan RB, Turaga KK, Eng OS. ASO Visual Abstract Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2023 Jan; 30(1)425. PMID 36071340.
Sneider AP, Dhiman A, Sood D, Ong C, Tun S, Malec M, Levine S, Turaga KK, Eng OS. Palliative Care and Characterization of Symptoms in Patients Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2023 03; 2831154-1160. PMID 36915007.
Ong CT, Schwarz JL, Roggin KK. Surgical considerations and outcomes of minimally invasive approaches for gastric cancer resection. Cancer. 2022 11 15; 128(22)3910-3918. PMID 36191278; PMCID PMC9828344.
Ong CT, Eng OS. ASO Author Reflections The Current Insurance Authorization Process and Future Directions for Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2023 01; 30(1) Call423-424-PMID 36183018.
Ong CT, Dhiman A, Smith A, Jose A, Kallakuri P, Belanski J, Sood D, Witmer HDD, Morgan RB, Turaga KK, Eng OS. Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2023 Jan; 30(1) Call417-422-PMID 36112250.
Sood D, Dhiman A, Ong CT, Liu AY, Belanski J, Turaga KK, Eng OS. The Impact of COVID-19-Related Delays on Surgical Management of Peritoneal Surface Malignancies. Ann Surg Oncol. 2022 09; 29(9)5377-5378. PMID 35503391; PMCID PMC9063612.
Park TS, Thomas SM, Rosenberger LH, Fayanju OM, Plichta JK, Blitzblau RC, Ong CT, Hyslop T, Hwang ES, Greenup RA. The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer. Ann Surg Oncol. 2018 Oct; 25(10)3019-3029. PMID 29978365; PMCID PMC6474911.
Ong CT, Campbell BM, Thomas SM, Greenup RA, Plichta JK, Rosenberger LH, Force J, Hall A, Hyslop T, Hwang ES, Fayanju OM. Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients A Retrospective Analysis of a National Oncology Database. Ann Surg Oncol. 2018 Aug; 25(8)2249-2260. PMID 29855830; PMCID PMC6039971.
Ong CT, Thomas SM, Blitzblau RC, Fayanju OM, Park TS, Plichta JK, Rosenberger LH, Hyslop T, Shelley Hwang E, Greenup RA. Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011. Ann Surg Oncol. 2017 Nov; 24(12)3559-3566. PMID 28879416; PMCID PMC5994237.
- Ages Accepted
-
AdultsGeriatrics